Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

ANDREW MICHAEL BLUMENFELD

Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology

NPI
1164459913
CMS profile
324864
Location
CARLSBAD, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2019 · Entire year

$892,735.02

1,011 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2019 · entire year · sorted by reported total

By paying entity

PY2019 · entire year · sorted by reported total

Page 19 of 21; records 901–950 of 1011 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

ANDREW MICHAEL BLUMENFELD

NPI 1164459913 · CMS profile ID 324864

Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Neurology

CARLSBAD, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 19 of 21; records 901–950 of 1011 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1164459913?year=2019&recipient=provider&page=19#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
ANDREW MICHAEL BLUMENFELD, NPI 1164459913, CMS profile ID 324864. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 19 of 21; records 901–950 of 1011 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1164459913?year=2019&recipient=provider&page=19#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
APA 7
IndustryPayments. (2026). ANDREW MICHAEL BLUMENFELD, NPI 1164459913, CMS profile ID 324864. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 19 of 21; records 901–950 of 1011 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1164459913?year=2019&recipient=provider&page=19#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
Bluebook
ANDREW MICHAEL BLUMENFELD, NPI 1164459913, CMS profile ID 324864, IndustryPayments, General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 19 of 21; records 901–950 of 1011 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e. https://industrypayments.org/provider/npi-1164459913?year=2019&recipient=provider&page=19#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2019 · Physicians and non-physician practitioners · CMS publication 2026-06-30

1,011 matching records · $892,735.02 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 1,011 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 901–950 of 1,011.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Sunovion Pharmaceuticals Inc. $18.9601/22/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 688166477 CMS
Teva Pharmaceuticals USA, Inc. $3,500.0001/22/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 697856547 CMS
Lilly USA, LLC $255.1201/21/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657673739 CMS
Lilly USA, LLC $318.0401/21/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657677137 CMS
Lilly USA, LLC $108.2301/21/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657677139 CMS
Lilly USA, LLC $244.5901/21/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657677141 CMS
Lilly USA, LLC $184.2601/21/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657677143 CMS
Lilly USA, LLC $191.4501/21/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657694419 CMS
Lilly USA, LLC $0.4801/21/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657694435 CMS
Lilly USA, LLC $83.4601/20/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657687569 CMS
Lilly USA, LLC $619.7801/20/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657694431 CMS
Allergan Inc. $6.7501/18/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670132021 CMS
Amgen Inc. $22.2301/18/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 662177169 CMS
Amgen Inc. $35.0001/18/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 662177183 CMS
Lilly USA, LLC $2,100.0001/18/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657673741 CMS
Lilly USA, LLC $4.7101/18/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657673753 CMS
Lilly USA, LLC $2,400.0001/18/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657687581 CMS
Teva Pharmaceuticals USA, Inc. $58.0001/18/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 697856747 CMS
Teva Pharmaceuticals USA, Inc. $22.9301/18/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 697856751 CMS
Allergan Inc. $5.0001/17/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670132019 CMS
Avanir Pharmaceuticals, Inc. $225.0001/17/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 653574379 CMS
Promius Pharma LLC $1.6701/17/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 701092703 CMS
Promius Pharma LLC $10.2501/17/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 701092705 CMS
Promius Pharma LLC $1,350.0001/17/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 701092799 CMS
Teva Pharmaceuticals USA, Inc. $479.9001/17/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 697856439 CMS
Teva Pharmaceuticals USA, Inc. $265.8101/17/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 697856551 CMS
Amgen Inc. $2,400.0001/16/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 662177185 CMS
Lilly USA, LLC $6.9801/16/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657677135 CMS
Lilly USA, LLC $50.0001/16/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657687553 CMS
Lilly USA, LLC $4.9501/16/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657697845 CMS
Lilly USA, LLC $80.0001/16/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657697847 CMS
Novartis Pharmaceuticals Corporation $16.1601/16/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658837177 CMS
Sunovion Pharmaceuticals Inc. $12.1101/16/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 688166473 CMS
Allergan Inc. $3,531.7501/15/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670132011 CMS
Allergan Inc. $2,415.0001/15/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670132013 CMS
Allergan Inc. $7,590.0001/15/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670132015 CMS
Allergan Inc. $4,830.0001/15/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670132017 CMS
Lilly USA, LLC $269.8601/15/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657677153 CMS
Lilly USA, LLC $78.8501/15/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657684065 CMS
Lilly USA, LLC $9.5401/15/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657687583 CMS
Lilly USA, LLC $286.9501/15/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657690991 CMS
Lilly USA, LLC $358.4101/15/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657694407 CMS
Lilly USA, LLC $454.6301/15/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657697849 CMS
Teva Pharmaceuticals USA, Inc. $1,016.6001/15/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 697856765 CMS
Amgen Inc. $20.7801/14/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 662177187 CMS
Amgen Inc. $1,494.3501/14/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 662177197 CMS
Allergan Inc. $91.5001/11/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670131999 CMS
Allergan Inc. $156.6401/11/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670132001 CMS
Allergan Inc. $17.7201/11/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670132003 CMS
Allergan Inc. $175.3001/11/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670132005 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $892,735.02 1,011
PY2020 $898,849.56 732
PY2021 $855,462.78 891
PY2022 $647,508.80 735
PY2023 $476,664.11 662
PY2024 $558,362.06 563
PY2025 $586,262.38 621

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $148,175.00 25
PY2024 Recipient $3,200.00 1
PY2023 Principal investigator $4,052.73 1
PY2022 Recipient $7,110.00 2
PY2021 Recipient $22.80 1
PY2020 Recipient $3,750.00 1
PY2020 Principal investigator $34.83 1
PY2019 Principal investigator $78.27 1

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

25 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 ABBVIE INC. $600.00 12/31/2025 Non-covered Recipient Entity
LISA G COOK MD INC
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Ubrogepant for the Preventive Treatment of Menstrual Migraine with an Open-Label Extension No dispute reported 06/30/2026 1202534255
Principal investigator 1 ABBVIE INC. $6,367.50 12/04/2025 Non-covered Recipient Entity
THE LOS ANGELES HEADACHE CENTER
Observational Study of Oral Atogepant to Evaluate Real-World Effectiveness in Adult Participants With Migraine (CORNERSTONE) No dispute reported 06/30/2026 1202526820
Principal investigator 1 ABBVIE INC. $1,620.00 12/04/2025 Non-covered Recipient Entity
THE LOS ANGELES HEADACHE CENTER
Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine No dispute reported 06/30/2026 1202526902
Principal investigator 1 ABBVIE INC. $7,582.50 11/05/2025 Non-covered Recipient Entity
THE LOS ANGELES HEADACHE CENTER
Observational Study of Oral Atogepant to Evaluate Real-World Effectiveness in Adult Participants With Migraine (CORNERSTONE) No dispute reported 06/30/2026 1202522741
Principal investigator 1 ABBVIE INC. $16,368.75 11/05/2025 Non-covered Recipient Entity
THE LOS ANGELES HEADACHE CENTER
Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine No dispute reported 06/30/2026 1202522743
Principal investigator 1 ABBVIE INC. $11,272.50 10/09/2025 Non-covered Recipient Entity
THE LOS ANGELES HEADACHE CENTER
Observational Study of Oral Atogepant to Evaluate Real-World Effectiveness in Adult Participants With Migraine (CORNERSTONE) No dispute reported 06/30/2026 1202514087
Principal investigator 1 ABBVIE INC. $9,483.75 10/09/2025 Non-covered Recipient Entity
THE LOS ANGELES HEADACHE CENTER
Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine No dispute reported 06/30/2026 1202514089
Principal investigator 1 Merz Pharmaceuticals, LLC $2,000.00 10/08/2025 Non-covered Recipient Entity
LISA COOK MD INC
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin Injections for Preventing Chronic Migraine No dispute reported 06/30/2026 1232647406
Principal investigator 1 Merz Pharmaceuticals, LLC $15,000.00 10/08/2025 Non-covered Recipient Entity
LISA COOK MD INC
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin Injections for Preventing Chronic Migraine No dispute reported 06/30/2026 1232647412
Principal investigator 1 ABBVIE INC. $2,966.25 09/04/2025 Non-covered Recipient Entity
THE LOS ANGELES HEADACHE CENTER
Observational Study of Oral Atogepant to Evaluate Real-World Effectiveness in Adult Participants With Migraine (CORNERSTONE) No dispute reported 06/30/2026 1202509230
Principal investigator 1 ABBVIE INC. $1,620.00 09/04/2025 Non-covered Recipient Entity
THE LOS ANGELES HEADACHE CENTER
Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine No dispute reported 06/30/2026 1202509232
Principal investigator 1 ABBVIE INC. $6,041.25 08/06/2025 Non-covered Recipient Entity
THE LOS ANGELES HEADACHE CENTER
Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine No dispute reported 06/30/2026 1202503503
Principal investigator 1 ABBVIE INC. $6,150.00 07/08/2025 Non-covered Recipient Entity
THE LOS ANGELES HEADACHE CENTER
Observational Study of Oral Atogepant to Evaluate Real-World Effectiveness in Adult Participants With Migraine (CORNERSTONE) No dispute reported 06/30/2026 1202497054
Principal investigator 1 ABBVIE INC. $1,800.00 07/02/2025 Non-covered Recipient Entity
THE LOS ANGELES HEADACHE CENTER
Observational Study of Oral Atogepant to Evaluate Real-World Effectiveness in Adult Participants With Migraine (CORNERSTONE) No dispute reported 06/30/2026 1202494275
Principal investigator 1 ABBVIE INC. $14,985.00 07/02/2025 Non-covered Recipient Entity
THE LOS ANGELES HEADACHE CENTER
Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine No dispute reported 06/30/2026 1202494277
Principal investigator 1 ABBVIE INC. $4,792.50 06/03/2025 Non-covered Recipient Entity
THE LOS ANGELES HEADACHE CENTER
Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine No dispute reported 06/30/2026 1202487931
Principal investigator 1 ABBVIE INC. $2,666.25 06/03/2025 Non-covered Recipient Entity
THE LOS ANGELES HEADACHE CENTER
Observational Study of Oral Atogepant to Evaluate Real-World Effectiveness in Adult Participants With Migraine (CORNERSTONE) No dispute reported 06/30/2026 1202487933
Principal investigator 1 ABBVIE INC. $1,485.00 05/07/2025 Non-covered Recipient Entity
THE LOS ANGELES HEADACHE CENTER
Observational Study of Oral Atogepant to Evaluate Real-World Effectiveness in Adult Participants With Migraine (CORNERSTONE) No dispute reported 06/30/2026 1202483201
Principal investigator 1 ABBVIE INC. $2,261.25 05/07/2025 Non-covered Recipient Entity
THE LOS ANGELES HEADACHE CENTER
Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine No dispute reported 06/30/2026 1202483203
Principal investigator 1 ABBVIE INC. $1,620.00 04/03/2025 Non-covered Recipient Entity
THE LOS ANGELES HEADACHE CENTER
Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine No dispute reported 06/30/2026 1202469059
Principal investigator 1 ABBVIE INC. $7,796.25 04/03/2025 Non-covered Recipient Entity
THE LOS ANGELES HEADACHE CENTER
Observational Study of Oral Atogepant to Evaluate Real-World Effectiveness in Adult Participants With Migraine (CORNERSTONE) No dispute reported 06/30/2026 1202469230
Principal investigator 1 ABBVIE INC. $6,986.25 03/07/2025 Non-covered Recipient Entity
THE LOS ANGELES HEADACHE CENTER
M23-714 - Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine No dispute reported 06/30/2026 1202459627
Principal investigator 1 ABBVIE INC. $3,105.00 02/06/2025 Non-covered Recipient Entity
THE LOS ANGELES HEADACHE CENTER
M23-714 - Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine No dispute reported 06/30/2026 1202449758
Principal investigator 1 ABBVIE INC. $10,500.00 01/28/2025 Non-covered Recipient Entity
THE LOS ANGELES HEADACHE CENTER
P24-880 - Observational Study of Oral Atogepant to Evaluate Real-World Effectiveness in Adult Participants With Migraine (CORNERSTONE) No dispute reported 06/30/2026 1202441700
Principal investigator 1 ABBVIE INC. $3,105.00 01/02/2025 Non-covered Recipient Entity
THE LOS ANGELES HEADACHE CENTER
M23-714 - Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine No dispute reported 06/30/2026 1202436107